NYSE:MDTMedical Equipment
Medtronic Sharpens Neurosurgery And Heart Focus With BCI And Valve Moves
Medtronic (NYSE:MDT) has entered into a partnership with Precision Neuroscience to advance brain computer interface technology in neurosurgery.
The company has also agreed to acquire a significant stake in Anteris Technologies, a developer of a transcatheter aortic valve replacement device.
For a medical technology giant like Medtronic, these moves touch two core areas: neurosurgery and structural heart care. Brain computer interface tools aim to bring new options into the operating room,...